| East Coast Biotech Roundup: PfizerGan, Nimbus, Intercept, Tesaro & More | Ben Fidler | 04/08/16 | Boston |
| In Need Of Revenues, Aastrom Buys Sanofi’s Cell Therapy Products | Sarah Schmid Stevenson | 04/25/14 | Detroit Ann Arbor |
| MVCA Celebrates Year’s Top Deals, Names New Board Chair | Sarah Schmid Stevenson | 11/08/13 | Detroit Ann Arbor |
| Michigan Life Sciences Roundup: Swift Biosciences, Aastrom | Sarah Schmid Stevenson | 03/11/13 | Detroit Ann Arbor |
| Aastrom Names New Interim CEO, Mayleben To Remain Active in Fundraising | Sarah Schmid Stevenson | 12/14/12 | Detroit Ann Arbor |
| Aastrom Closes $40 Million Financing Deal with Eastern Capital | Sarah Schmid Stevenson | 03/09/12 | Detroit Ann Arbor |
| Xconomist of the Week: Tim Mayleben on Building University Startups | Sarah Schmid Stevenson | 02/09/12 | Detroit Ann Arbor |
| Aastrom Reports Positive Phase 2 Trial Results | Sarah Schmid Stevenson | 11/15/11 | Detroit Ann Arbor |
| Aastrom Enters Final-Stage Trial With Stem-Cell Therapy for CLI Patients | Sarah Schmid Stevenson | 08/09/11 | Detroit Ann Arbor |
| Aastrom Announces $22.5M Public Offering to Help Fund Stem Cell Trials | Howard Lovy | 12/10/10 | Detroit Ann Arbor |
| Uncle Sam Delivers $18.4M in Research Awards to Michigan Biotechs | Ryan McBride | 11/05/10 | Detroit Ann Arbor |
| Aastrom Maps Out Pivotal Trial Strategy With Adult Stem Cell Therapy | Luke Timmerman | 10/22/10 | Detroit Ann Arbor |
| Aastrom Gets FDA Fast Track Status, Gears Up for Pivotal Study of Cell Therapy | Luke Timmerman | 10/18/10 | Detroit Ann Arbor |
| Five Things Michigan Entrepreneurs and Innovators Are Already Doing to Invigorate the State’s Economy | Gerry Roston | 07/06/10 | Detroit Ann Arbor |
| Aastrom Shows Off Vascular Results | Luke Timmerman | 06/11/10 | Detroit Ann Arbor |
| Aastrom Biosciences Seeks to Catch Cell Therapy Wave, Ride Dendreon’s Coattails | Luke Timmerman | 06/02/10 | Detroit Ann Arbor |
